tetano
Editor, Senior Moderator
Int Urol Nephrol
. 2021 Nov 22.
doi: 10.1007/s11255-021-03059-3. Online ahead of print.
Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
Charalampos Loutradis[SUP] 1 2 [/SUP], Apostolos G Pitoulias[SUP] 3 [/SUP], Eleni Pagkopoulou[SUP] 4 [/SUP], Georgios A Pitoulias[SUP] 3 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19) is associated with increased mortality in patients with chronic kidney disease (CKD), dialysis patients and kidney transplant recipients (KTR). Cardiovascular complications, such as sudden arrhythmias, thromboembolic events, coronary events, cardiomyopathies and heart failure, may present in about 10-20% of patients with COVID-19. Patients with CKD, dialysis patients and KTR are all at increased cardiovascular risk and present with more cardiovascular complications after COVID-19 compared to the general population. During the pandemic, health care giving has rapidly changed by reducing elective outpatient reviews, which may refrain these high-risk patients from the appropriate management of their medical conditions, further increasing cardiovascular risk. Importantly, acute kidney injury (AKI) is another common complication of severe COVID-19 and associates with increased mortality. A large proportion of the AKI patients need renal replacement treatment, while 30% of them may not present renal function recovery and remain dialysis-dependent after discharge, thereby having potentially increased future cardiovascular risk. This review summarizes current knowledge regarding the cardiovascular events and mortality in patients with CKD or undergoing hemodialysis and in KTR.
Keywords: COVID-19; Cardiovascular Disease; Chronic Kidney Disease; Hemodialysis; Renal Transplantation.
. 2021 Nov 22.
doi: 10.1007/s11255-021-03059-3. Online ahead of print.
Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
Charalampos Loutradis[SUP] 1 2 [/SUP], Apostolos G Pitoulias[SUP] 3 [/SUP], Eleni Pagkopoulou[SUP] 4 [/SUP], Georgios A Pitoulias[SUP] 3 [/SUP]
Affiliations
- PMID: 34811606
- DOI: 10.1007/s11255-021-03059-3
Abstract
The coronavirus disease 2019 (COVID-19) is associated with increased mortality in patients with chronic kidney disease (CKD), dialysis patients and kidney transplant recipients (KTR). Cardiovascular complications, such as sudden arrhythmias, thromboembolic events, coronary events, cardiomyopathies and heart failure, may present in about 10-20% of patients with COVID-19. Patients with CKD, dialysis patients and KTR are all at increased cardiovascular risk and present with more cardiovascular complications after COVID-19 compared to the general population. During the pandemic, health care giving has rapidly changed by reducing elective outpatient reviews, which may refrain these high-risk patients from the appropriate management of their medical conditions, further increasing cardiovascular risk. Importantly, acute kidney injury (AKI) is another common complication of severe COVID-19 and associates with increased mortality. A large proportion of the AKI patients need renal replacement treatment, while 30% of them may not present renal function recovery and remain dialysis-dependent after discharge, thereby having potentially increased future cardiovascular risk. This review summarizes current knowledge regarding the cardiovascular events and mortality in patients with CKD or undergoing hemodialysis and in KTR.
Keywords: COVID-19; Cardiovascular Disease; Chronic Kidney Disease; Hemodialysis; Renal Transplantation.